These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 11399666

  • 1. Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat.
    Arbin V, Claperon N, Fournié-Zaluski MC, Roques BP, Peyroux J.
    Br J Pharmacol; 2001 Jun; 133(4):495-502. PubMed ID: 11399666
    [Abstract] [Full Text] [Related]

  • 2. Effects of dual angiotensin-converting enzyme and neutral endopeptidase 24-11 chronic inhibition by mixanpril on insulin sensitivity in lean and obese Zucker rats.
    Arbin V, Claperon N, Fournié-Zaluski MC, Roques BP, Peyroux J.
    J Cardiovasc Pharmacol; 2003 Feb; 41(2):254-64. PubMed ID: 12548087
    [Abstract] [Full Text] [Related]

  • 3. Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker.
    Wang CH, Leung N, Lapointe N, Szeto L, Uffelman KD, Giacca A, Rouleau JL, Lewis GF.
    Circulation; 2003 Apr 15; 107(14):1923-9. PubMed ID: 12668518
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats.
    Damas J, Hallet C, Lefebvre PJ.
    Br J Pharmacol; 2001 Nov 15; 134(6):1312-8. PubMed ID: 11704652
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 8. ACE inhibition and glucose transport in insulinresistant muscle: roles of bradykinin and nitric oxide.
    Henriksen EJ, Jacob S, Kinnick TR, Youngblood EB, Schmit MB, Dietze GJ.
    Am J Physiol; 1999 Jul 15; 277(1):R332-6. PubMed ID: 10409290
    [Abstract] [Full Text] [Related]

  • 9. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
    Henrion D, Dechaux E, Dowell FJ, Maclour J, Samuel JL, Lévy BI, Michel JB.
    Br J Pharmacol; 1997 May 15; 121(1):83-90. PubMed ID: 9146891
    [Abstract] [Full Text] [Related]

  • 10. Neutral endopeptidase and angiotensin-converting enzyme inhibitors increase nitric oxide production in isolated canine coronary microvessels by a kinin-dependent mechanism.
    Zhang X, Nasjletti A, Xu X, Hintze TH.
    J Cardiovasc Pharmacol; 1998 Apr 15; 31(4):623-9. PubMed ID: 9554814
    [Abstract] [Full Text] [Related]

  • 11. Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure.
    Zhang X, Recchia FA, Bernstein R, Xu X, Nasjletti A, Hintze TH.
    J Pharmacol Exp Ther; 1999 Feb 15; 288(2):742-51. PubMed ID: 9918584
    [Abstract] [Full Text] [Related]

  • 12. Marked difference between angiotensin-converting enzyme and neutral endopeptidase inhibition in vivo by a dual inhibitor of both enzymes.
    Anastasopoulos F, Leung R, Kladis A, James GM, Briscoe TA, Gorski TP, Campbell DJ.
    J Pharmacol Exp Ther; 1998 Mar 15; 284(3):799-805. PubMed ID: 9495836
    [Abstract] [Full Text] [Related]

  • 13. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
    Miyamoto A, Murata S, Nishio A.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May 15; 365(5):365-70. PubMed ID: 12012022
    [Abstract] [Full Text] [Related]

  • 14. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C, Seidl U, Reinecke A, Riester U, Graf K, Schultheiss HP, Hilgenfeldt U, Unger T.
    Int Immunopharmacol; 2003 Mar 15; 3(3):335-44. PubMed ID: 12639811
    [Abstract] [Full Text] [Related]

  • 15. New dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme: rational design, bioavailability, and pharmacological responses in experimental hypertension.
    Fournié-Zaluski MC, Coric P, Turcaud S, Rousselet N, Gonzalez W, Barbe B, Pham I, Jullian N, Michel JB, Roques BP.
    J Med Chem; 1994 Apr 15; 37(8):1070-83. PubMed ID: 8164250
    [Abstract] [Full Text] [Related]

  • 16. In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation.
    Zappellini A, Teixeira SA, Muscará MN, Zatz R, Antunes E, De Nucci G.
    Eur J Pharmacol; 1996 Dec 19; 317(2-3):285-91. PubMed ID: 8997612
    [Abstract] [Full Text] [Related]

  • 17. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ, Anastasopoulos F, Duncan AM, James GM, Kladis A, Briscoe TA.
    J Pharmacol Exp Ther; 1998 Nov 19; 287(2):567-77. PubMed ID: 9808682
    [Abstract] [Full Text] [Related]

  • 18. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
    Resende AC, Pimentel AM, de Moura RS.
    Clin Exp Pharmacol Physiol; 2004 Nov 19; 31(11):756-61. PubMed ID: 15566389
    [Abstract] [Full Text] [Related]

  • 19. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    Gonzalez Vera W, Fournié-Zaluski MC, Pham I, Laboulandine I, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1995 Jan 19; 272(1):343-51. PubMed ID: 7815350
    [Abstract] [Full Text] [Related]

  • 20. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC.
    Ann Thorac Surg; 1995 Sep 19; 60(3):789-92. PubMed ID: 7545893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.